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Background: Sub-retinal pigment epithelial
deposits contain complement proteins and
bioavailable zinc.
Result: Ultracentrifugation and X-ray
scattering show that >100 µM zinc induces
oligomer formation in each of C3, C3u, and
C3b, in analogy to Factor H.
Conclusion: Factor H-C3b complexes are
precipitated by zinc which inhibits
complement activation.
Significance: A potential molecular
mechanism for zinc-induced sub-retinal
deposit formation is clarified.
SUMMARY
The sub-retinal pigment epithelial deposits
(sRPEds) that are a hallmark of age-related
macular degeneration (AMD) contain both
C3b and mM levels of zinc. C3 is the central
protein of complement, while C3u is formed
by the spontaneous hydrolysis of the
thioester bridge in C3. During activation,
C3 is cleaved to form active C3b, then C3b
is inactivated by Factor I and Factor H to
form the C3c and C3d fragments. The
interaction of zinc with C3 was quantified
using analytical ultracentrifugation and X-
ray scattering. C3, C3u, and C3b associated
strongly in >100 µM [Zn], while C3c and
C3d showed weak association. With zinc,
C3 forms soluble oligomers, while C3u and
C3b precipitate. We conclude that the C3,
C3u and C3b association with zinc
depended on the relative positions of C3d
and C3c in each protein. Computational
predictions showed that putative weak zinc
binding sites with different capacities exist
in all five proteins, in agreement with
experiment. Factor H forms large oligomers
in >10 µM [Zn]. In distinction to C3b or
Factor H alone, the solubility of the central
C3b-Factor H complex was much reduced
at 60 µM [Zn], and even more so at >100
µM [Zn]. The removal of the C3b-Factor H
complex by zinc explains the reduced
C3u/C3b inactivation rates by zinc. Zinc-
induced precipitation may contribute to the
initial development of sRPEds in the retina,
as well as reducing the progression to
advanced AMD in higher-risk patients.
INTRODUCTION
Activation of the complement system
through the classical, lectin and alternative
pathways leads to the conversion of C3 to C3b
(1,2). C3 is the most abundant complement
protein in plasma (about 1.0 mg/ml or 5.3 µM)
and is an acute phase protein whose
concentration increases during inflammation.
C3 is a member of the α2-macroglobulin 
family (3). Unactivated C3 consists of 13
domains, namely eight macroglobulin domains
MG1 to MG8, a linker domain (LNK), an
anaphylatoxin domain (ANA; C3a), a
complement C1r/C1s-UEGF-BMP1 domain
(CUB), a thioester-containing domain (TED;
C3d), and a C345C domain (Figure 1A) (4).
The spontaneous hydrolysis of the thioester
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2bond in the TED/C3d domain leads to C3u
(also known as C3H2O or C3i), also with 13
domains (Figure 1B). The formation of
convertase enzyme complexes (such as those
originating from complement Factor B)
cleaves the ANA/C3a domain from C3 to form
C3b. Conformational changes occur in C3b to
expose the highly reactive thioester bond,
which enables C3b to bind covalently to the
cell surface (3). Despite structural similarities
with C3b, C3u is unable to bind to surfaces
due to its hydrolysed thioester bond. When
C3b is bound to the pathogen cell surface, a
positive-feedback amplification leading to
increased C3b production occurs (2).
Following C3b binding to Factor H (FH), C3b
is cleaved by Factor I to yield inactive C3c and
C3dg, hence regulating the amounts of active
C3b (1,2). FH consists of 20 short complement
regulator (SCR) domains. The N-terminal
domains SCR-1/4 bind to C3b between its
TED/CUB and MG domains (5), while the C-
terminal domains SCR-19/20 binds to the
TED/C3d domain of C3b (6,7). Additional
C3b binding sites may occur in the middle of
FH (8,9).
The complement proteins including
C3 and FH are genetically associated with age-
related macular degeneration (AMD) (10-19).
AMD is a leading cause of visual impairment
in the elderly in the western world (11,13). A
hallmark of AMD is the appearance of sub-
retinal pigment epithelial deposits (sRPEds)
within Bruch’s membrane, an extracellular
matrix layer between the retinal pigment
epithelium (RPE) and the choroidal
microvasculature (20-22). sRPEds contain
oxidized lipids, carbohydrates and over 100
proteins, including the complement
components, and trace elements (11,23,24).
Zinc is the second most abundant trace mineral
in the human body, and ocular tissues contain
unusually high concentrations of zinc (25,26).
The secretion of zinc from zinc-rich RPE cells
is elevated under oxidative stress (27). High
mM levels of zinc were identified in sRPEds
and Bruch’s membrane using X-ray
fluorescence, with some being in a bio-
available form as shown by fluorescent probes
(28). Interestingly, zinc inhibits the cleavage
of C3b by FH, and FH aggregates in the
presence of zinc (29,30). Recently, both
heterozygous and homozygous FH were each
shown to self-associate indefinitely through its
SCR-6/8 domains with a dissociation constant
of ~10 µM (31,32). While zinc has no
measurable effect on Factor I, zinc was
reported to bind to C3 (33,34). Here, in order
to complete our studies of the FH-zinc
complexes, we have now quantified the
comparative effects of zinc on the self-
association of C3, C3u, C3b, C3c and C3d,
and its effect on the centrally-important
regulatory C3b-FH complex.
Zinc binding sites at protein interfaces
are often formed from His, Asp, Glu and/or
Cys residues (35). A shared zinc site between
two protein surfaces involves between one to
three residues from each surface. To determine
the extent to which surface-bound zinc cause
each of C3, C3u, C3b, C3c and C3d to self-
associate, we employed analytical
ultracentrifugation and synchrotron X-ray
scattering (36), combined with metal binding-
site predictions for these proteins (37). In
comparison to our recent FH-zinc studies
(31,32), we found here that the C3, C3u and
C3b oligomerise with [Zn] > 100 M in a ten-
fold weaker manner than the zinc-induced
oligomerisation of FH. For the key regulatory
C3b-FH complex, we showed that zinc leads
to the precipitation of this complex at >100
µM zinc concentrations. Our results explain
why C3b cleavage by FH and Factor I is
inhibited by zinc (31,34). Molecular
mechanisms are suggested for the initial
formation of sRPEds that lead to AMD, as
well as an explanation for the role of zinc in
reducing the occurrence of developing
advanced AMD in high risk patients (38,39).
EXPERIMENTAL PROCEDURES
Protein purification and
concentrations - Wild-type C3 was purified
from fresh human plasma by anion-exchange
using a Q-Sepharose fast-flow column
(Amersham Biosciences) and a Mono Q 5/50
GL column (Pharmacia GE Healthcare) (40).
C3u was produced by incubating C3 with 200
mM hydrazine for 2 h at 37oC in a water bath,
and leaving this overnight at 4oC. C3b was
produced by treating 1 mg/ml C3 in HEPES
buffer (10 mM HEPES, 137 mM NaCl, 0.5
mM EDTA, pH 7.4) with 10 µg/ml trypsin
(1% w/w enzyme/substrate) for 120 s at 37oC
in a water bath, then adding 40 µg/ml soybean
trypsin inhibitor to stop cleavage before
transferring onto ice. To block the free SH
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3group of the C3b thioester, 20 mM
iodoacetamide was added to the mixture, then
this was incubated in the dark at 20oC for 30
min (5). The C3b sample was diluted in Tris
buffer (25 mM Tris, 140 mM NaCl, 0.5 mM
EDTA, pH 8.0), then concentrated
immediately and passed through a Superose™
6 prep grade XK 16/60 size-exclusion column.
C3c was prepared by incubating outdated
human plasma for seven days at 37oC in a
water bath, then following the same protocol
for the purification of C3 to produce C3c. C3u
and C3b (but not C3) were active in functional
assays using Factor I and Factor H (31).
Recombinant C3d with a GST tag was
expressed in E. coli, and purified using a
GSTrap FF 5 ml column (GE Healthcare)
connected to a HiTrap Benzamidine FF (high
sub) 1 ml column (GE Healthcare) (41). Wild-
type FH was purified from outdated human
plasma using monoclonal affinity
chromatography (32). The absorbance
coefficients for C3, C3u, C3b, C3c, C3d and
FH (1%, 280 nm, 1 cm path length) were
calculated from their compositions to be 9.40,
9.40, 9.83, 9.21, 13.15 and 16.2 respectively,
assuming the presence of three high-mannose
type oligosaccharides at Asn63, Asn917 and
Asn1597 in C3 (42,43). Molecular masses
were calculated from compositions to be 189.0
kDa for C3 and C3u, 179.3 kDa for C3b, 135.7
kDa for C3c, 34.6 kDa for C3d, and 154.4 kDa
for FH. All proteins were passed through a
size-exclusion gel filtration column to remove
potential aggregates immediately prior to the
addition of zinc, then dialysed into HEPES
buffer without EDTA. Each protein was
routinely checked by SDS-PAGE before and
after the ultracentrifugation and scattering
experiments. Complement haemolytic activity
assays were performed in triplicate using an
alternative pathway kit based on the lysis of
chicken erythrocytes in an agarose gel
(Binding Site Group Ltd., Birmingham, UK).
The diameter of the zones of lysis was
measured using a jewellers’ eyepiece as a
measure of complement activation.
Sedimentation velocity data collection
and analyses - Analytical ultracentrifugation
data were obtained on two Beckman XL-I
instruments equipped with AnTi50 rotors,
using two-sector cells with column heights of
12 mm at a rotor speed of 50,000 r.p.m.
Sedimentation velocity experiments at 20oC
were performed with C3 at 0.76 mg/ml (4.0
µM), C3u at 0.87 mg/ml (4.6 µM), C3b at 0.79
mg/ml (4.4 µM), C3c at 0.6 mg/ml (4.4 µM),
and C3d at 0.27 mg/ml (7.8 µM). Zinc
titrations utilised ZnSO4 at concentrations of
0.2 µM, 6 µM, 20 µM, 60 µM, 120 µM, 200
µM and 600 µM. The C3b-FH complex was
formed by incubating C3b at 0.99 mg/ml (5.5
µM) with FH at 0.85 mg/ml (5.5 µM) at 4oC
overnight, followed by sedimentation velocity
the following morning at a rotor speed of
50,000 r.p.m. at 20oC. Interference data were
analysed for C3, C3u and the C3b-FH complex
titrated with zinc and absorbance data were
analysed for C3b, C3c and C3d titrated with
zinc, using SEDFIT software (version 14.1)
(44,45). The size distribution analyses c(s)
provided size and shape data for each species
present by directly fitting the observed
sedimentation boundaries to the Lamm
equation, using 300 interference boundaries
for C3, C3u and C3b-FH, and 25-80
absorbance boundaries for C3b, C3c and C3d.
The c(s) analyses were based on a fixed
resolution of 200, in which the meniscus, the
bottom of the cell, the baseline and the average
frictional ratio f/fo were floated until the
overall root mean square deviation and the fits
between the observed and calculated
sedimentation boundaries were satisfactory.
The starting f/fo values were between 1.35 to
1.4 for C3, C3u, C3b and C3c, 1.2 for C3d,
and 1.78 for the C3b-FH complex, Monomers
and oligomers of C3, C3u, C3b, C3c and C3d
were quantitated using the integration function
in the c(s) analyses. The integrations assumed
that the signal intensities of the monomer at
the lowest zinc concentrations is 100%. Other
details are described elsewhere (31,46).
X-ray scattering data collection and
analyses - X-ray scattering data was acquired
in two beam sessions on Instrument ID02 at
the European Synchrotron Radiation Facility
(Grenoble, France) operating with a ring
energy of 6.0 GeV in 4-bunch and 16-bunch
mode to reduce the incident flux (47). The
sample-detector distance was 3.0 m, and the
X-ray wavelength was 0.0995 nm. Potential
radiation damage was eliminated by the
continuous movement of the sample in a flow
cell during beam exposure, the use of 10 time
frames of duration between 0.1 sec and 0.5 sec
each during each acquisition, and on-line
checks for the absence of radiation damage at
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4low Q. In the first beam session, C3 and C3u
were at 0.76 mg/ml (4 μM), C3b at 0.72 mg/ml 
(4 μM), C3c at 0.54 mg/ml (4 μM) and C3d at 
0.50 mg/ml (14.5 μM), all in HEPES buffer. In 
the second beam session, C3b was at 0.90
mg/ml (5.0 M), FH at 0.77 mg/ml (5.0 M),
and the C3b-FH complex was formed by
incubating the mixture at 4oC two hours before
adding zinc, all in HEPES buffer with 0.5 mM
Pefabloc-SC70. ZnSO4 was added at
concentrations of 2 μM, 6 μM, 20 μM, 60 μM, 
120 μM, 200 μM and 600 μM up to 2 h before 
the measurements. Other details including data
reduction are described elsewhere (46,48).
In a given solute-solvent contrast, the
radius of gyration RG corresponds to the mean
square distance of scattering elements from
their centre of gravity, and is a measure of
structural elongation. Guinier analyses at low
Q values gives the RG value and the forward
scattering at zero angle I(0) from the
expression (49):
ln I(Q) = ln I(0) - RG2 Q2/3.
This expression is valid in a Q.RG range up to
1.5. The I(0)/c value (c is the protein
concentration in mg/ml) is proportional is the
relative molecular mass Mr. The Guinier
analyses were performed using an interactive
PERL script program SCTPL7 (J. T. Eaton
and S. J. Perkins, unpublished software) on
Silicon Graphics OCTANE Workstations.
Indirect transformation of the I(Q)
curve measured in reciprocal space into real
space gives the distance distribution function
P(r) and was carried out using the program
GNOM (50):
P(r) corresponds to the distribution of
distances r between volume elements, and
gives an alternative calculation of the RG and
I(0) values based on the full scattering curve
I(Q). It also gives the most frequently
occurring distance M within the
macromolecule and the maximum dimension
of the macromolecule L. For C3, C3u, C3b,
C3c and C3d titrated with zinc, the X-ray
curves utilised up to 320 data points in the Q
range between 0.09 nm-1 and 1.50 nm-1. Other
details are described elsewhere (31,46,48).
Prediction of zinc binding sites -
Potential zinc binding sites were predicted
utilising the METSITE server (37). METSITE
(http://bioinf.cs.ucl.ac.uk/web_servers/)
predicts binding sites for different metals
utilising a broad set of structural identifiers.
For a given metal, the characterisation of the
secondary structure, solvent accessibility,
position-specific scoring matrix and distance
matrix ascertains those residues most likely to
interact strongly with metal. METSITE utilises
the distances between the Cβ atoms of amino 
acid residues except for Gly residues when Cα 
atoms were used. For this project, the capacity
of METSITE was expanded by Dr Daniel
Buchan and Prof David T. Jones in order to
process larger protein structures. The
predictions used crystal structures for C3
(PDB code 2A73) (4), C3b (PDB codes 2I07
and 2ICF) (51,52), C3c (PDB code 2A74) (4),
and C3d (PDB codes 1C3D and 1GHQ (53,54)
and a solution structure for C3u (PDB code
3MMQ) (43). In METSITE, the false positive
rate was set to 5% and the predicted metal was
set to zinc. For structures with multiple chains,
all chains were relabelled to be chain A in
order to circumvent a METSITE limitation of
only being able to process single chain
structures. His, Glu, Asp and Cys residues
with neural network scores greater than 0.7
were accepted as potential zinc binding
residues, while Arg and Gly residues were
removed because they do not bind zinc (35).
The METSITE output was summarized in
tabular form, in which a neural network
residue score of 0.7 represents a log likelihood
ratio of approximately 1. At a log likelihood
ratio of 2, there are 100 correct predictions for
every false positive, indicating a high level of
confidence (37).
RESULTS
Sedimentation velocity of C3, C3u,
C3b, C3c and C3d with zinc - C3, C3u, C3b
and C3c were studied at concentrations of
4.04.6 M which are comparable with the
physiological C3 concentration of about 1.0
mg/ml (5.3 M) in plasma (2). C3d was
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5lowest concentration that produced analysable
data. HEPES buffer was used in order to avoid
the precipitation of zinc that occurs if
phosphate buffer is used. Each protein was
titrated using a concentration range of 0.2-600
μM ZnSO4.
Analytical ultracentrifugation studies
the sedimentation behaviour of
macromolecules when they are subjected to a
high centrifugal force in order to determine
their sizes and shapes (55). This method is
advantageous for the detection of multiple
species that are present. In sedimentation
velocity experiments with C3, C3u, C3b, C3c
and C3d, each was titrated with zinc. Good fits
to the sedimentation boundaries in all cases
(Figure 1F) resulted in well-defined size
distribution analyses c(s). The five proteins
each showed different sedimentation
behaviour as [Zn] increased:
(i) For C3 titrated with zinc, the
monomer peak was consistently observed at an
s20,w value of 8.42 ± 0.10 S with a molecular
mass (MM) value of 182 ± 4 kDa at all [Zn]
values (Figure 1A). Both values agree well
with those of C3 without zinc at 8.49 ± 0.03 S,
and 192 ± 8 kDa, and with the sequence-
determined MM of 189.0 kDa (43).1 The
intensity of the C3 monomer peak decreased
as [Zn] increased. This indicated the presence
of unperturbed C3 monomer even with a 40-
fold excess of zinc, meaning the binding of
zinc is weak. Starting from [Zn] of 60 M, the
monomer peak broadened, and a second broad
peak appeared that corresponded to soluble C3
oligomers with higher s20,w values of 10.2 S at
60 M zinc, 12.3 S at 120 M zinc and 13.7 S
at 200 M zinc (Figure 1A). The apparent MM
of these peaks were 244 kDa, 321 kDa and 378
kDa respectively, suggesting that progressive
C3 oligomer formation as dimer or trimer or
higher has occurred in the presence of excess
zinc.
(ii) For C3u titrated with zinc, the
monomer peak was consistently observed at an
s20,w value of 8.05 ± 0.11 S with a MM value
of 176 ± 3 kDa at all [Zn] values. These values
agreed with those of C3u without zinc at 8.08
1 FOOTNOTE: Our previous study (43) reported s
values of 7.85 ± 0.05 S for C3 and 7.44 ± 0.07 S for
C3u, when these should have been presented as
s20,w values of 8.49 ± 0.03 S and 8.08 ± 0.02 S
respectively.
± 0.03 S and 172 ± 16 kDa (43). Unlike C3,
the C3u monomer peak almost disappeared as
[Zn] increased to 120 M and 200 M, and no
significant oligomer peaks were observed at
high [Zn] values (Figure 1B). This showed that
C3u precipitated in the presence of excess
zinc.
(iii) For C3b, the monomer peak was
observed at a s20,w value of 7.41 ± 0.01 S and a
MM value of 160 ± 0.3 kDa for [Zn] up to 20
M (Figure 1C). At [Zn] of 60 M and above,
the monomer s20,w value increased slightly,
going from 7.62 S at 60 M zinc to 7.76 S at
200 M zinc. The peak shift is attributed to the
onset of C3b oligomer formation in the
presence of zinc, this being less pronounced
than that observed for C3. At the same time,
the C3b peak intensity also decreased as [Zn]
increased, indicating precipitation. No separate
oligomer peak was observed for C3b-zinc
(Figure 1C). Thus C3b behaved differently
from C3 or C3u in the presence of zinc.
(iv) For C3c, the monomer peak was
observed at a s20,w value of 6.51 ± 0.07 S with
a MM value of 121 ± 2 kDa at all [Zn] values.
This agrees with that for C3c in the absence of
zinc. No change in s20,w value or intensity was
observed until [Zn] reached 200 M when the
monomer peak became broader, this being
attributed to the onset of C3c oligomer
formation (Figure 1D).
(v) For C3d, the monomer was
consistently observed at a s20,w value of 3.13 ±
0.09 S with a MM value of 34 ± 1 kDa, and no
significant oligomer peak was visible. These
data agree well with the s20,w value of 3.0 ± 0.1
S and a MM value of 34 ± 4 kDa for
monomeric C3d in 137 mM NaCl (56).
Starting at [Zn] of 60 μM, the C3d monomer 
peak decreased in intensity as [Zn] increased,
but less so than C3, C3u and C3b (Figure 1E).
The integration of the monomer peak
intensities in the c(s) analyses permitted
comparison of the effect of zinc on the
solubility of the five proteins. For reason of
clarity, the integrations were normalised to
100% at 0-2 M [Zn] values. C3, C3u and C3b
decreased significantly at [Zn] of 120 M and
above with similar apparent protein-zinc
dissociation constants KD of around 100 M
(Figure 2A). C3 and C3u decreased more
strongly in intensity than C3b at [Zn] of 120
M and above. Of those three proteins, only
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6C3 formed soluble oligomers that increased to
about 80% of the C3 present. This increase in
C3 oligomer matched the decrease of the C3
monomer for [Zn] of 120 M and above.
Unlike C3, C3u and C3b, the C3c monomer
was not affected in intensity by increase in
[Zn] up to 200 M, while the amount of the
C3d monomer was slightly reduced at [Zn]
above 60 M and 64% of C3d remained as a
soluble monomer in 200 M zinc (Figure 2B).
Neither C3c nor C3d precipitated or formed
large oligomers in the manner seen for C3,
C3u and C3b. It was concluded that the
presence of both the C3d and C3c regions
within C3, C3u and C3b is required for these
to self-associate with zinc, even though either
C3d or C3c on their own do not self-associate
with zinc.
To assess whether other plasma
proteins undergo self-association in the
presence of zinc, 0.32 mg/ml (4 M) of human
serum albumin in HEPES buffer was titrated
with seven concentrations of ZnSO4 between
0.2-600 M. The c(s) analyses revealed one
major peak at a s20,w value of 4.95 ± 0.06 S and
a MM value of 67 ± 1 kDa that was unaltered
in 0.2-600 M zinc (data not shown). This
indicated that human serum albumin does not
self-associate in the presence of zinc.
Sedimentation velocity of the C3b-FH
complex with zinc - Sedimentation velocity
experiments were performed on a 1:1 mixture
of FH at 0.85 mg/ml (5.5 M) and C3b at 0.99
mg/ml (5.5 M) (Figure 3A). The KD value is
0.6-1.6 µM for the FH-C3b complex (9).
Accordingly, 60-70% FH-C3b complex
formation is expected. Unbound monomeric
FH was observed at a s20,w value of 5.58 S, and
this corresponded to a MM value of 143 kDa
which is close to the sequence-predicted mass
of 154 kDa (Figure 3B). The peak with a s20,w
value of 9.18 S and a MM value of 287 kDa
was attributed to the 1:1 complex of FH-C3b
with a sequence-predicted MM value of 334
kDa. Unbound monomeric C3b was an
unresolved shoulder at a s20,w value of ~7.5 S
that overlapped with the major peak at 9.18 S.
Small amounts of other species were observed
at s20,w values higher than 10 S, however their
peaks were not well resolved and were not
considered further here.
The effect of zinc on the 1:1 complex
of C3b and FH was now investigated. Given
that the KD for the FH-zinc interaction is ~10
µM (31,32), and that for C3b-zinc is ~100 µM
(Figure 2A), both zinc interactions are weaker
than that for the FH-C3b complex. Good fits to
the sedimentation boundaries with 60 M, 120
M and 200 M of zinc were obtained in all
cases (Figure 3C). On adding zinc, the peak
for monomeric FH at 5.58 S was consistently
observed at all [Zn] values (Figure 3D). The
peak intensity of monomeric FH decreased
from 100% with no zinc to 43% at 200 M
zinc. At 60 M zinc, multiple peaks with s20,w
values up to 50 S were observed. The intensity
of these oligomer peaks were much higher
than for only FH with 60 M zinc, and both
the FH monomer and C3b-FH peaks decreased
in intensity, indicating that these peaks
correspond to a mixture of FH-Zn and C3b-
FH-Zn oligomers [Figure 1 of (32)]. At 120
M and 200 M zinc, these multiple peaks
showed clear decreases in intensity, showing
that the C3b-FH-zinc oligomers precipitated
when zinc was above 100 . The
corresponding experiment with FH in 200 M
zinc showed that FH-zinc oligomers were
much more soluble in the absence of C3b (32).
In addition, the major peak for the C3b-FH
complex at 9.18 S was reduced in 60 M and
120 M zinc, and disappeared in 200 M zinc.
These decreased peak intensities with 120-200
M zinc is attributed to the formation of very
large C3b-FH-zinc complexes that precipitate
and sediment rapidly to the bottom of the
ultracentrifuge cell, even before the first scan
was recorded.
X-ray scattering of C3, C3u, C3b, C3c
and C3d with zinc - Small-angle X-ray
scattering is a diffraction method for the study
of solution structures of macromolecules in
random orientations (57). The effect of zinc on
freshly-purified C3, C3u, C3b, C3c and C3d
were investigated by X-ray scattering. C3,
C3u, C3b and C3c were again studied at 4 μM, 
while C3d was studied at 14.5 μM (0.50 
mg/ml), this being the lowest concentration of
C3d that produced analysable X-ray data. Each
protein was titrated with 2 μM to 600 μM 
ZnSO4. The scattering data I(Q) showed
excellent signal-noise ratios and no detectable
effect from radiation damage.
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(where Q = 4π sin θ /λ; 2θ = scattering angle; λ 
= wavelength) detect aggregates more readily
than ultracentrifugation (31). The Guinier
radius of gyration (RG) monitors the degree of
elongation of the protein, and Guinier I(0)/c
value is proportional to the relative MM
(49,57). The fits for the five proteins were
performed in a restricted Q range from 0.14 to
0.22 nm-1, even though good Guinier linearity
continued to 0.45 nm-1 at low [Zn], because
this reduced Q range provided a sensitive
monitor for aggregation:
(i) For C3 at the lowest [Zn] of 2 M,
and for 6 M, 20 M and 60 M zinc, the
mean RG value was 5.43 ± 0.02 nm, which is
higher than that of 4.52 ± 0.08 nm for native
C3 without zinc in the larger Q range from
0.13 to 0.30 nm-1 (43). This increase is
attributed to minor aggregation of C3, the
latter being visible as a slight upturn in the
scattering curve at the lowest Q values (Figure
4A). For 120 M, 200 M and 600 M zinc,
the I(Q) intensities increased significantly at
low Q values as the result of zinc-induced
aggregation. At larger Q values, these I(Q)
intensities dropped for reason of protein losses
(precipitation). These I(Q) changes led to
significant increases in the apparent RG value
which represents the average RG values of the
monomeric and aggregated species (Figure
5A) (58).
(ii) For C3u at [Zn] of 2 M, the mean
RG value was 5.18 ± 0.16 nm, which is close to
the value of 4.88 ± 0.23 nm in the Q range
from 0.13 to 0.30 nm-1 for C3u without zinc
(43). Some minor aggregation was visible at
the lowest Q values (Figure 4B). As for C3,
little changes occurred at 6-60 M zinc, while
significant increases in intensity and the
apparent RG value were seen at 120-600 M
zinc (Figure 5A). In this case, the larger
decrease in intensities at the larger Q values
showed that more protein precipitation of C3u
occurred at 120-600 M zinc.
(iii) For C3b with 2 M zinc, the mean
RG value was 4.73 ± 0.16 nm, which is close to
that of 4.88 ± 0.23 nm above for C3u without
zinc (43). As for C3 and C3u, little changes
occurred for [Zn] at 6-60 M. Significant
increases in intensity and apparent RG value
were seen for [Zn] at 120-600 M, together
with protein precipitation seen at larger Q
(Figures 4C and 5A). The increased
aggregation with increase in [Zn] is more
clearly seen in the curves that were replotted
with offsets (Figure 4F).
(iv) For C3c with 2 M zinc, the mean
RG value was 4.50 ± 0.13 nm with 2 M zinc;
this RG value is similar to those for C3u and
C3b above. Unlike C3, C3u and C3b, the
scattering curves showed little change for [Zn]
up to 60 M, and only modest increases in
intensities for zinc from 120 M to 600 M
(Figure 4D). The apparent RG increases were
much smaller than those seen for C3, C3u and
C3b (Figure 5A).
(v) For C3d with 2 M zinc, the
apparent RG value of C3d was 2.98 ± 0.30 nm
in the Q range of 0.14 to 0.22 nm-1 (Figure
4E). C3d is small and a larger Guinier Q fit
range is normally used. The RG value was 1.95
nm in the Q fit range of 0.16 to 0.55 nm-1, in
good accord with the RG value of 2.02 nm
calculated from its crystal structure (59). Here,
the Guinier fits with a Q range of 0.14 to 0.22
nm-1 were almost unchanged between 2 μM to 
600 μM zinc. At the lowest Q values below
0.14 nm-1, intensity increases were seen for
200 μM and 600 μM zinc, showing that slight 
aggregates have formed, together with some
minor precipitation seen at large Q (Figure
4E). The apparent RG increases were the
smallest compared to the other four proteins
(Figure 5A). It was concluded that C3d
remained mostly monomeric in solution for
[Zn] between 2 μM to 600 μM.  
When aggregates are present, the
observed scattering curve is the sum of the
scattering curves of the macromolecular
species present (58). The apparent RG values
showed that C3 exhibited the strongest zinc-
induced oligomerisation, followed by C3u,
C3b, C3c and C3d in that order (Figure 5A).
The corresponding changes in the I(0)/c values
was best analysed using baseline Guinier I(0)/c
values from a second Q fit range between 0.32
and 0.45 nm-1. The difference Δ between the 
two I(0)/c values compensated for protein
precipitation that reduced the I(0)/c values
(Figure 5B). The ΔI(0)/c values showed that
C3 exhibited the strongest oligomerisation,
followed by C3u, C3b, C3c and C3d in that
order. These are consistent with the
integrations from ultracentrifugation (Figure
2).
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reports on the protein shapes of the zinc-
induced aggregates of the five proteins. The
P(r) curve gives the distances between all
pairs of atoms within the macromolecule. This
leads to the most frequently occurring distance
M from the position of the peak maximum, the
maximum length L from the point at which
P(r) becomes zero at large Q, and an
independent calculation of the RG and I(0)
values for comparison with the above Guinier
values (57). In summary, the five P(r) analyses
showed that C3, C3u and C3b aggregated
strongly with [Zn] of 120 M and above,
while C3c and C3d showed little significant
effects:
(i) For C3 in 2 μM zinc, M was 5.0 nm
and L was 16 nm (Figure 6A). These values
were identical with those for C3 without zinc
(43). For 6-60 μM zinc, M increased from 5.0
nm to 6.7 nm, L increased from 16 nm to 19
nm, and the area under the P(r) curve doubled.
The changes indicated small amounts of C3
aggregate formation. For 120-600 M zinc, the
area under the P(r) curves underwent large
increases, together with increases in L from 16
nm to 50 nm. It was concluded that aggregates
of C3-zinc had formed that were over three
times larger than the C3 monomer.
(ii) For C3u in 2 μM zinc, M was 5.1
nm and L was 16 nm (Figure 6B). These
values agreed closely with those of C3u
without zinc (43). Up to 60 M zinc, the P(r)
curves remained similar with modest increases
in intensity and L. In 120 M to 600 M zinc,
the P(r) intensity for C3u below 16 nm
decreased, while the P(r) curves became
significantly broader with L values that
increased to about 50 nm. The L values for the
C3u-zinc aggregates were similar to that for
C3-zinc. For 120 M and 200 M zinc, the
reduced P(r) intensities compared to those for
C3 suggested that C3u aggregated less than
C3.
(iii) For C3b in 2 μM zinc, M was 4.8
nm and L was 16 nm (Figure 6C), these being
similar to those for C3 and C3u above. The
P(r) curves remained almost unchanged with
increases up to 60 M zinc. Between 120 M
to 600 M zinc, the P(r) curves changed in a
similar manner to that of C3u, except that the
intensity changes were smaller compared to
those of C3 and C3u, suggesting that C3b
aggregated less than C3u.
(iv) For C3c in 2 M zinc, M was 4.5
nm and L was 14 nm (Figure 6D). Unlike C3,
C3u and C3b, the P(r) curve remained almost
unchanged with only a small increase in L to
18 nm when [Zn] increased to 200 M. In 600
M zinc, M became 5.5 nm and L became 22
nm, together with slight increases in the P(r)
intensity. These small changes reflected little
C3c aggregation between 2 M to 600 M
zinc.
(v) For C3d in 2 M zinc, M was 2.63
nm and L was 6 nm (Figure 6E; not drawn to
scale). These values agreed with those of C3d
without zinc (59). Between 2 M to 600 M
zinc, the M and L values and the shape of the
P(r) curves were almost unchanged, with only
slight decreases in the P(r) intensity above 120
M zinc that may result from slight C3d
precipitation. These small changes also
reflected little C3d aggregation between 2 M
to 600 M zinc.
Scattering curves of the FH-C3b-zinc
complex - The FH-C3b complex in the
presence of zinc was studied by X-ray
scattering. The Guinier fits (not shown) were
performed in the same Q ranges of 0.14 to
0.22 nm-1 for the apparent RG and I(0)/c
values, and 0.32 to 0.45 nm-1 for the I(0)/c
baseline. Each of C3b, FH and their 1:1
mixture were titrated with 2 M to 600 M
zinc (Figure 5C,D). On the addition of zinc,
both Guinier parameters for FH increased
rapidly in agreement with those previously
seen with FH-zinc (31,32). Those for C3b
increased more slowly, in agreement with
Figure 5A,B. Those for the FH-C3b mixture
increased with zinc to follow initially the
results with FH-zinc. At [Zn] above 100 M,
when C3b started to bind to zinc, both the RG
and I(0)/c parameters decreased. These
decreases above 100 M zinc are attributable
to the formation of very large complexes of
FH and C3b with zinc, which precipitate out of
solution and no longer contribute to the
scattering curves. These results are consistent
with ultracentrifugation that showed that the
C3b-FH-zinc complexes precipitated (Figure
3C,D).
Alternative pathway activation assay -
To investigate whether zinc affected the
complement alternative pathway, an
alternative pathway haemolytic complement
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study the effect of zinc sulphate on
complement activation in human serum.
Between 0-100 M zinc, the activity decreased
by about 10%, and between 100-5000 M
zinc, the activity diminished by a further 10%
(Figure 7). The results are explained by the
precipitation of C3b-FH-zinc complexes, thus
reducing the availability of C3b to mediate its
normal inflammatory response.
Computational zinc-binding
predictions for C3, C3u, C3b, C3c and C3d -
Zinc binding sites are generally
formed from four residues that are co-
ordinated by zinc (35). To clarify the
molecular basis of C3 self-association with
zinc, surface zinc binding sites were predicted
from seven crystal and solution structures for
C3, C3u, C3b, C3c and C3d (Table 1). These
were submitted to the METSITE prediction
server (37). METSITE was developed using
relative residue positions, and does not require
side-chain atoms to be present, therefore its
predictions are applicable to low resolution
structures. METSITE has an estimated site
sensitivity of 77% and site selectivity of 44%
for zinc predictions (Table 3 of (37)). Multiple
partial zinc binding sites composed of His, Glu
and Asp residues were predicted on the surface
of all five structures when the neural network
output residue score was >0.7 to correspond to
strong hits (Table 1). No well-defined zinc
binding sites were observed, and the number
of sites varied from protein to protein. If the
zinc binding capacity corresponds to the
number of predicted zinc-binding residues per
100 residues, C3 has 2.4 unique zinc binding
site residues, followed by C3b at 1.8-2.9
residues, C3u at 1.8 residues, C3c at 1.5
residues and C3d with 1.0-1.3 residues. A
separate prediction for the CUB domain
(which is not present in C3c or C3d) showed
no zinc binding residues in CUB from C3, and
one His residue in CUB from C3u. Overall, the
predictions show that weak zinc binding to the
surfaces of C3, C3u and C3b explains their
oligomer formation. The comparative Table 1
predictions were consistent with the
experimental ultracentrifugation and scattering
data showing strong oligomerisation in C3,
C3u and C3b, and weaker effects on C3c and
C3d.
The front and back surfaces of the five
C3 proteins showed that the partial zinc
binding site predictions were broadly
distributed (Figure 8). Many sites were not
reproducibly predicted between the five
different structures; this variability is
attributed to the weak zinc binding affinity.
Given these moderate accuracies, zinc
oligomer formation could not be assigned to
specific residues in the five proteins.
Nonetheless, the lack of zinc-induced
oligomers for C3c and C3d is attributable to
insufficient totals of weak zinc sites for daisy-
chaining via zinc to form oligomers (Figure
8D). When C3c and C3d are present together
in C3, C3u and C3b, the zinc sites in C3c and
C3d were able to pair and cross-link C3, C3u
or C3b with zinc (Figure 8A-C). The large
soluble C3-zinc oligomers, in contrast to the
precipitation seen with C3u-zinc and C3b-zinc,
are attributable to the different location of C3d
relative to C3c in the three proteins.
In order to test whether METSITE was
able to identify partial zinc binding sites,
structures with zinc located at the interface
between two distinct domains were tested (35).
A nerve growth factor (PDB code 1SGF) was
split into two domains (chains G and A) in
order to predict the four ligands at the zinc
binding site between them. In the separated
domains, METSITE identified two clearly,
namely His202 and Glu207 in domain G
(scores of 0.91 and 0.98 respectively), plus a
third one Glu51 (score of 0.55) but not the
fourth His58 in domain A. When the intact
protein was analysed, three of the four ligands
was correctly predicted. A carbonic anhydrase
(PDB code 1THJ) predicted one site (chain A
His117, score 0.8), but two were missed (chain
B His81 score 0.45, and chain B His122, no
score). This outcome was the same when the
intact protein or the two separate domains
were analysed. The comparisons confirm that
the METSITE predictions were moderately
effective at detecting weak zinc binding sites.
DISCUSSION
Our detailed study of the C3, C3u and
C3b interactions with zinc revealed that these
proteins underwent different forms of self-
association at zinc concentrations above 100
µM (Table 2). With zinc, C3 formed large
oligomers, C3u and C3b precipitated, and C3c
and C3d showed little self-association. Most
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importantly, strong precipitation was observed
when zinc was added to the key physiological
C3b-FH complex (Figure 9C,D), and the
activation of the complement alternative
pathway was detectably inhibited by zinc.
These results suggest that, in inflammatory
conditions, the pathophysiological release of
zinc at unexpectedly high concentrations into
the extracellular space has the capacity to
perturb the complement system and initiate
protein oligomer deposition.
Extracellular metal-induced protein
aggregation is significant in several
degenerative diseases such as in Alzheimer’s
disease, amyloid and prion diseases, and age-
related macular degeneration where
extracellular zinc concentrations can reach
high M or even mM levels due to the release
of zinc from neighbouring cells (60, 61). The
local elevation in extracellular zinc levels is
likely to be the result of pathological events,
even though during neuronal activity, Zn is
released into the synaptic cleft and is believed
to reach local concentrations of 300 µM (62).
A number of ratiometric zinc sensors estimate
the intracellular bioavailable zinc levels to be
in the nM to pM range in resting cultured cells,
which can be compared to the total
intracellular zinc concentration of about 100
µM (63). While the extracellular bioavailable
zinc levels are yet to be precisely determined,
indications are that these will also be in the
nM to pM range, similar to intracellular
bioavailable zinc levels. Thus bioavailable
zinc levels in plasma are in a range of 20-210
pM (64). In plasma, the total zinc level
remains steady at 14.7 M even after a daily
diet supplement with 80 mg zinc in the
AREDS trials (38). Most plasma zinc (84%) is
bound to human serum albumin with a KD of 1
M, and α2-macroglobulin binds 15% of 
plasma zinc (65). Compared to KD values of
approximately 100 M for C3/C3u/C3b-zinc
binding and 10 M for FH-zinc binding,
human serum albumin acts as a scavenger of
bioavailable zinc, and accordingly there is
little risk of C3/C3u/C3b or FH self-
association with zinc in normal plasma
conditions. The same is likely to be true for the
extracellular space in a resting stage. However
pathological events may trigger the release of
high concentrations of zinc locally, especially
in tissues where zinc concentration are
exceptionally high such as the RPE (25).
Zinc appears to be essential for the
normal function of the retina, but its exact
involvement in normal and pathological
functions is unclear (27). Intracellular zinc is
mostly bound to proteins including
metallothioneins, carbonic anhydrase and
other zinc binding proteins (25,27,66). RPE
cells are able to accumulate zinc following
oral supplementation, and retain this zinc for
longer than any other tissues in the body,
suggesting a special process for zinc storage
and distribution in these cells (66). Zinc levels
can also decrease in RPE cells under
pathological conditions such as that seen in
AMD (66), releasing zinc into Bruch’s
membrane where it could bind to proteins and
induce their aggregation in vivo. These
aggregated proteins then become part of
sRPEds (28). We have shown that Bruch’s
membrane contains bioavailable zinc,
especially in samples that contain substantial
sRPEds, evidenced by their labelling in the
presence of selective fluorescence sensors that
only bind to bioavailable zinc (67). This
bioavailable zinc could lead to the formation
of the C3-zinc, C3u-zinc and C3b-zinc and
C3b-FH-zinc complexes (Figure 8a) as well as
to those for FH-zinc complexes (31). Our zinc
concentrations from 100 M upwards, at
which we observed oligomerisation separately
with each of C3, C3u, C3b, and with the C3b-
FH complex, therefore have biomedical
significance in the eye.
The zinc-binding studies with
C3/C3u/C3b show that these proteins exhibit
different modes for their self-association in the
presence of >100 M zinc (Figures 2, 5 and 6).
Zinc has therefore been useful as a probe of
structural differences between these three
proteins, adding to the knowledge already
obtained with the crystallography of C3 and
C3b and the constrained scattering modelling
of C3u (4,43,51). The more compact C3d-C3c
arrangement in C3 promotes larger soluble
oligomers with zinc, while the more extended
C3d-C3c arrangements in C3u and C3b
promote greater precipitation with zinc (Figure
9A). The fact that zinc had little effect on each
of C3c or C3d suggests that both of these are
involved in zinc binding only when they are
together in C3, C3b or C3u. At zinc above 10
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M (30,31,32), strong oligomerisation
occurred for both the wild-type Tyr402 and
disease-related His402 allotypes at the SCR-
6/8 domains (32). Indefinite daisy-chains of
cross-linked SCR-6/8 domains accounted for
the large FH oligomers, starting from a simple
dimer (Figure 9B). Our new results showing
that C3b self-associated with zinc, and that the
C3b-FH complex precipitated with 100 M
zinc have changed this understanding. The
combination of separate C3b-zinc and FH-zinc
self-associations in the C3b-FH complex
promotes even greater amounts of oligomer
formation (Figure 9E). Each FH dimer will
bind to two C3b dimers; in turn, each C3b
dimer will bind to two FH dimers. Two
separate weak zinc-binding events with μM 
affinities becomes a much stronger interaction
when both events occur simultaneously in
different parts of the same complex (68).
FH is a major complement regulator,
and is expressed and secreted by many
different cell types including the RPE (69).
Factor H and C3 have been detected in retinal
and RPE/choroidal tissues (70). The major
physiological ligands of FH include C3b and
its C3d fragment, heparan sulphate and other
glycosaminoglycans, and C-reactive protein
(71). All these ligands bind weakly to FH with
M affinities, as expected given the M
abundance of FH in serum. Thus C3b and C3d
bind to FH with KD values of 0.6-1.6 M and
2.6 M respectively (9,72), heparin binds to
two sites on FH with KD values of 1-3 µM
(73), and C-reactive protein binds with a KD
value of 4-15 M (74). If C3b at 1 mg/ml is
mixed with FH at 0.8 mg/ml, only 60-70% of
complex is formed with a KD value of 0.6-1.6
M. This illustrates how complement
regulatory control is achieved as the result of
incomplete complex formation between its
major ligands. When pathophysiological
amounts of >100 M zinc are present, together
with high levels of localised inflammation
(when much C3b is formed), our results show
that zinc will precipitate and remove the C3b-
FH complex and free C3b. The normal
mechanisms of complement control that
involves multiple interactions with C3b,
heparan sulphate and C-reactive protein
become perturbed (71).
In summary, we propose that during
AMD-associated inflammation, two
influencing factors need to be considered: (i)
the release of 10-100 M bioavailable zinc
will affect the oligomerisation and activity of
FH (31); (ii) if zinc concentrations increase
even further, C3b will also form oligomers but
more importantly any C3b-FH complexes that
are formed in Bruch’s membrane will
precipitate in >100 M zinc. The C3b-FH-zinc
precipitates will contribute to sRPEd
formation. This may explain the presence of
FH, C3b and other complement proteins in
sRPEds (11). However, while the reduction of
FH levels will promote uncontrolled
inflammation, the precipitation of C3b-zinc
and C3b-FH-zinc complexes will limit that.
Therefore, clinically, zinc might contribute to
the early and late stages of AMD in two
distinct ways (75). Whether the beneficial
effects of zinc supplementation (38) is related
to the precipitation of C3b-FH-zinc complexes
will need to be determined.
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TABLE 1. METSITE predictions of zinc binding residues for the protein structures of C3, C3u, C3b,
C3c and C3d. The single neural network cut-off threshold was set at 0.7 in order to represent the log

















C3 2A73 13 1611 38 2.4
C3b 2ICF 12 1545 45 2.9
C3b 2I07 12 1531 27 1.8
C3u 3MMQ 13 1531 28 1.8
C3c 2A74 10 1109 17 1.5
C3d 1C3D 1 294 3 1.0
C3d 1GHQ 1 307 4 1.3
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TABLE 2. Summary of the effect of zinc on the five forms of C3, FH and the C3b-FH complex.
Aggregation is considered to be the sum of oligomer formation and precipitation. The outcomes of
Figures 1-6 are summarised using the following codes: A, aggregation; ma, minor aggregation; O,
oligomer; P, precipitation; mp, minor precipitation; MP, major precipitation; n.a., not applicable.
Protein Fig. 1 Fig 2 Fig. 3 Fig. 4 Fig. 5 Fig. 6 Overall
C3 O O n.a. A A O O
C3u P P n.a. A, P A O, P P
C3b P P n.a. A, P A O, P P
C3c - - n.a. a A - mp
C3d - mp n.a. a ma - mp
FH n.a. n.a. O n.a. A n.a. O
C3b.FH n.a. n.a. MP n.a. MP n.a. MP
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FIGURE LEGENDS
Figure 1. Sedimentation velocity analyses of C3, C3u, C3b, C3c and C3d in the presence of zinc.
C3, C3u, C3b and C3c were studied at 4.4 µM and C3d was studied at 7.8 µM. The 10-13 domains of
C3, C3u, C3b and C3c are depicted as cartoons with the TED (circle or hexagon) and ANA (triangle)
domains shown in dark outlines when present. Beneath the c(s) plots, a schematic summary of the
relationships between the five forms of C3 is shown. Oligomers, precipitates or no changes upon
adding zinc are denoted by P, O and – respectively.
A, The c(s) sedimentation coefficient distribution analysis for C3 with [Zn] at 2 µM ( ), 20 µM (
), 60 µM ( ), 120 µM ( ) and 200 µM ( ). The monomer peak is
denoted as M, and the oligomer peaks at high S values are denoted as O. Here and below, the
zinc concentrations in µM are denoted numerically.
B, The c(s) analysis for C3u with [Zn] at 0.2 µM ( ) and 6 µM ( ), and three higher [Zn]
values are shown as in A;
C, The c(s) analysis for C3b, with [Zn] at 0.2 µM ( ), 6 µM ( ) and 20 µM (……..),and
three higher [Zn] values are shown as in A;
D, The c(s) analysis for C3c with [Zn] shown as in C;
E, The c(s) analysis for C3d with [Zn] shown as in C;
F, The sedimentation boundary fits for C3b with 200 µM zinc; all 30 scans are shown. The
experimental absorbance data are shown as black circles, while the boundary fits are shown as
grey lines.
Figure 2. The percentages of the monomers and oligomers of the five C3 proteins as a function
of [Zn]. These were determined from the c(s) analyses of Figure 1.
A, C3 (● monomer; ○ oligomer; ); C3u (▲ monomer; ); C3b (■ monomer; ).
B, C3c ( monomer; ); C3d (▼ monomer; ). 
Figure 3. Sedimentation velocity analyses of the C3b-FH complex in the presence of zinc.
A, The boundary fits for the 1:1 mixture of 5.5 µM C3b and 5.5 µM FH. Only every tenth scan of the
300 scans are shown for clarity. The absorbance data is shown as black circles, while
boundary fits are shown as grey lines.
B, The c(s) sedimentation coefficient distribution analysis for the 1:1 mixture of C3b and FH. The
peak positions for the FH monomer (5.77 S), C3b monomer (8.16 S) and the 1:1 C3b-FH
complex (9.55 S) are arrowed.
C, The boundary fits for the 1:1 mixture of 5.5 µM FH-C3b and 5.5 µM FH with 200 µM zinc,
following the representation of A.
D, The c(s) analyses for the 1:1 mixture of FH:C3b with 60 µM, 120 µM and 200 µM zinc (black
outlines). The analyses are normalised relative to the FH monomer peak. The zinc
concentrations are denoted numerically. The peak position of the 1:1 FH-C3b complex is
arrowed. For comparison, the two c(s) curves (grey outlines) for the complex from B with no
zinc present and for FH alone with 200 µM zinc from Figure 4D of (31) are shown to the
same scale.
Figure 4. X-ray Guinier analyses of ln I(Q) vs. Q2 for C3, C3u, C3b, C3c and C3d titrated with
zinc. For clarity, the 10-13 domains of C3, C3u, C3b and C3c are depicted as cartoons. In all panels,
the open symbols correspond to the experimental data and the filled symbols correspond to those used
for the Guinier straight line fits. The Q fit range was 0.14-0.22 nm-1 in all cases (arrowed ranges), and
the zinc concentrations in µM are numerically labelled as shown. The Guinier RG plots are shown for
A, C3; B, C3u; C,F, C3b; and D, C3c, all at approximately 4 µM, and for E C3d at 14.5 µM. The
ZnSO4 concentrations were 2 µM (○), 6 µM (Δ), 20 µM (□), and 60 µM (▽), all shown in black, and
120 µM (○), 200 µM (Δ), and 600 µM (□), all shown in grey. In F, the C3b Guinier plots from C are
displaced in steps of 0.2 log units to shown the processes of aggregation and precipitation more
clearly.
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Figure 5. Dependence of the Guinier RG and I(0)/c parameters on zinc concentrations from 2 to
600 µM. Each value was measured in quadruplicate and averaged, and statistical error bars are shown
where visible.
A, The apparent RG values for C3 (●, ), C3u (▲, ), C3b (■, ), C3c ( , ) 
and C3d (▼, ……..) were determined from the fits of Figure 4A-E.
B, The change in the I(0)/c values between the Guinier plots, the difference being based on the Q fit
ranges of 0.14 - 0.22 nm-1 and 0.32 - 0.45 nm-1 for C3, C3u, C3b, C3c and C3d, using the
same symbols as in A.
C, The apparent RG values for FH (○, ), the FH-C3b complex (●, ), and C3b (■, 
) measured in another beam session are compared with each other (the Guinier fits are
not shown).
D, The change in the I(0)/c values between the Guinier plots, the difference being based on the Q fit
ranges of 0.14 - 0.22 nm-1 and 0.32 - 0.45 nm-1 for FH, the C3b-FH complex and C3b, using
the same symbols as in C.
Figure 6. Dependence of the distance distribution function P(r) of C3, C3u, C3b, C3c and C3d
on zinc concentrations from 2 to 600 µM. For clarity, the 10-13 domains of C3, C3u, C3b and C3c
are depicted as cartoons. The P(r) curves were calculated from the I(Q) curves used in Figure 4. A,
C3; B, C3u; C, C3b; D, C3c; and E, C3d. The zinc concentrations were 2 µM ( ), 6 µM (
), 20 µM ( ), 60 µM ( ), all shown in black, and 120 µM ( ), 200 µM ( ),
600 µM ( ), all shown in grey. Panels A-D are drawn to the same scale for clarity of
comparison. The zinc concentrations in µM are denoted numerically.
Figure 7. Effect of zinc on alternative pathway activation in human serum. Human serum was
made 0 µM, 100 µM, 250 µM, 500 µM, 750 µM, 1000 µM, 2000 µM, 3000 µM, 4000 µM and 5000
µM in zinc. Radial diffusion activity assays were performed and normalised to 0 µM. The experiment
was performed in triplicate, and the mean ± standard error of each measurement is shown.
Figure 8. Surface view of the METSITE predictions for C3, C3u, C3b, C3c and C3d. Each
structure is displayed as the front view on the left, and rotated 180º about the vertical axis to show the
back view on the right. Residues highlighted in red represent the METSITE predictions that were
registered above a neural network score of 0.7. The PDB codes are A, 2A73 for C3; B, 3MMQ for
C3u; C, 2I07 for C3b; and D, 2A74 for C3c and 1C3D for C3d.
Figure 9. Schematic outlines of the zinc-induced oligomerisation of FH-zinc, C3b-zinc, and C3b-
FH-zinc complexes.
A, A putative C3b dimer is shown in which the C3c and C3d regions in yellow and red respectively in
two monomers are cross-linked by zinc. Other cross-linked forms of C3b can also be formed by the
daisy-chaining of the cross-linking.
B, A putative FH dimer is shown in which the SCR-6/8 domains are cross-linked by zinc. These
structures can also be daisy chained to form larger oligomers.
C,D, The crystal structure of C3b with SCR-1/4 of FH is shown as a cartoon form and as a molecular
structure (PDB code 2WII) to which SCR-5/20 from the folded-back solution structure of FH SCR-
1/20 (PDB code 3GAV; R. Nan, unpublished modelling) is added to indicate their interaction. C3b is
shown in yellow (with the CUB domain in blue and the TED domain in red) and FH is shown in
green.
E, The formation of large aggregates of C3b-FH-zinc is shown. The daisy-chaining of the two dimers
shown in A and B is accompanied by the formation of the C3b-FH complex to form an aggregated
particle. Further FH monomers (in purple) are able to bind to the two C3b dimers, and these purple
FH monomers are also able to bind zinc and dimerise further.
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